ERLI PLUS XR 10/1000MG TAB

Erli Plus XR 10/1000 mg combines empagliflozin 10 mg and metformin extended-release 1000 mg in one tablet.

It is used for type 2 diabetes mellitus, especially when a single medicine doesn’t control blood sugar adequately.

Empagliflozin helps the kidneys excrete more glucose in urine; metformin lowers glucose production in the liver and improves insulin sensitivity.

The “XR” (extended release) part means metformin is released more slowly, reducing gastrointestinal side effects.

Normally taken once daily, with or after food, to reduce stomach upset.

Possible side effects include diarrhea, nausea, increased urination, risk of genital or urinary tract infections, dizziness, or dehydration.

Not to be used in people with severe kidney impairment, diabetic ketoacidosis, or those allergic to either component; regular monitoring required.